bpc-157 safety research Many peptides people use to self-treat – like to boost injury recovery – have not been rigorously studied in humans. But an FDA panel just recommended loosening restrictions on BPC-157, and BPC-157: A Briefing for Healthcare

Anyone using BPC-157 should monitor liver enzymes and kidney function and work with a provider

About the Authors Medically reviewed by Phyllis J

The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)

Regular, effective workouts are key to creating the calorie deficit needed for weight loss and for improving body composition